Abstract
The MDM2 proto-oncogene plays a key role in central cellular processes like growth control and apoptosis, and the gene locus is frequently amplified in sarcomas. Two polymorphisms located in the MDM2 promoter P2 have been shown to affect cancer risk. One of these polymorphisms (SNP309T
Cite
CITATION STYLE
APA
Knappskog, S., Gansmo, L. B., Romundstad, P., Bjørnslett, M., Trovik, J., Sommerfelt-Pettersen, J., … Lønning, P. E. (2012). MDM2 promoter SNP344T>A (rs1196333) status does not affect cancer risk. PLoS ONE, 7(4). https://doi.org/10.1371/journal.pone.0036263
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free